MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-26-0106484
Epione Pharmaceuticals Private Limited - pharma in Pune, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹12.66 Cr
▲ 11% YoY
Net profit · FY 2024
₹79.04 Lakh
Net margin 6.2%
EBITDA · FY 2024
₹1.24 Cr
EBITDA margin 9.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
14 yrs
Est. 2012
Employees · EPFO
129
Provident fund records
Directors on board
4
As per MCA filings
About Epione Pharmaceuticals Private Limited
Data last updated:
Epione Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 June 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24233PN2012PTC143777. Its GSTIN is 27AADCE0854E1ZX (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Pankaj Shah Sumatilal and Vipul Shah Pankaj.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Pune, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹12.66 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹79.04 Lakh (net margin 6.2%) and EBITDA of ₹1.24 Cr (EBITDA margin 9.8%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 21% over five years.
The company has about 129 employees on its provident fund (EPFO) records.
Epione Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0106484). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website epionepharma.com.
Company details
CIN U24233PN2012PTC143777
Registration Number 143777
Incorporation Date 21 June 2012
ROC Pune
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-26-0106484
Recognitions & Rankings of Epione Pharmaceuticals
Contact details
Epione Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra. Its website is epionepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressOffice No.804 8th Floor Suyog Center Jawaharlal Nehru Road Market Yard – Gulte, Kdi, Pune, Maharashtra, India – 411037
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Epione Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Epione Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Epione Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Epione Pharmaceuticals Private Limited, buy the company report.
Financials of Epione Pharmaceuticals Private Limited
FY 2024 filings availableEpione Pharmaceuticals Private Limited reported revenue of ₹12.66 Cr (up 11% YoY) for FY 2024.
Revenue · FY 2024
₹12.66 Cr ▲ 11%
Net profit · FY 2024
₹79.04 Lakh margin 6.2%
EBITDA · FY 2024
₹1.24 Cr margin 9.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 26%
5 years · compounded
▲ 21%
EBITDA CAGR growth
1 year
▼ 30%
3 years · compounded
▲ 1%
5 years · compounded
▲ 25%
Revenue has grown at a compounded annual rate (CAGR) of 21% over five years, including 11% growth in the latest year. EBITDA fell 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹12.66 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.24 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹79.04 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.8% | ||||
| Net Profit Margin | 6.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Epione Pharmaceuticals Private Limited, buy the company report.
Board of directors of Epione Pharmaceuticals Private Limited
Epione Pharmaceuticals has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pankaj Shah Sumatilal | Director | 29 Nov 2021 | 4 Years 11 Months | Current |
| Vipul Shah Pankaj | Director | 29 Nov 2021 | 4 Years 11 Months | Current |
| Rekha Shah Pankaj | Director | 10 Apr 2018 | 8 Years 7 Months | Current |
| Rushika Shah Vipul | Director | 16 Jan 2018 | 8 Years 9 Months | Current |
Auditor
Epione Pharmaceuticals Private Limited is audited by GIRISHBHERUMALGUNDESHA for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GIRISHBHERUMALGUNDESHA | FY 2024 | 042885 |
Shareholding
The shareholding of Epione Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Epione Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Epione Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Epione Pharmaceuticals Private Limited has 7 MSME Form 1 returns on record between 2019 and 2023, listing 34 overdue payments to 5 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 5)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Nenshi Formulation | |||
| Biostrum Nutritech Private Limited | |||
| Cian Healthcare Limited | |||
| Medico Intercontinental Limited | |||
| Leo Nutriscience LLP |
To see the full MSME payment records of Epione Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Epione Pharmaceuticals Private Limited has a workforce of 129 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
129
Active EPFO establishments
1
Employee growth
-2.3%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 129 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Epione Pharmaceuticals Private Limited, buy the company report.
GST
Epione Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCE0854E1ZX | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Epione Pharmaceuticals Private Limited, buy the company report.
Recent activity
Epione Pharmaceuticals Private Limited has 7 board changes on record since 2018: 4 appointments and 3 cessations. The latest: Pankaj Shah Sumatilal was appointed as Director on 29 Nov 2021.
AGM
Epione Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Epione Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune.
Appointed
Pankaj Shah Sumatilal was appointed as Director.
Appointed
Vipul Shah Pankaj was appointed as Director.
Ceased
Rekha Shah Pankaj ceased to be Additional Director.
Ceased
Pankaj Shah Sumatilal ceased to be Whole-Time Director.
Ceased
Vipul Shah Pankaj ceased to be Managing Director.
Appointed
Rekha Shah Pankaj was appointed as Director.
Appointed
Rushika Shah Vipul was appointed as Director.
Incorporation
21 Jun 2012
Epione Pharmaceuticals Private Limited was registered on 21 Jun 2012 with Roc Pune & aged 14 years 4 months as per MCA records.
Frequently asked questions
Epione Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 June 2012 (14+ years old) and is registered under CIN U24233PN2012PTC143777.
Epione Pharmaceuticals has 4 current directors:
- Pankaj Shah Sumatilal - Director
- Vipul Shah Pankaj - Director
- Rekha Shah Pankaj - Director
- Rushika Shah Vipul - Director
The latest financial statements of Epione Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Epione Pharmaceuticals is 27AADCE0854E1ZX, registered in Maharashtra.
The CIN (Corporate Identification Number) of Epione Pharmaceuticals is U24233PN2012PTC143777. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Epione Pharmaceuticals was incorporated on 21 June 2012, making it 14+ years old. It is registered with the Registrar of Companies, Pune.
Pankaj Shah Sumatilal was appointed as Director on 29 Nov 2021. Vipul Shah Pankaj was appointed as Director on 29 Nov 2021. Rekha Shah Pankaj ceased to be Additional Director on 29 Sep 2018. Epione Pharmaceuticals has 7 board changes on record in total.
Yes, Epione Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-MH-26-0106484).
Epione Pharmaceuticals has 7 MSME Form 1 returns on record between 2019 and 2023, listing 34 overdue payments to 5 micro and small suppliers. The latest return was filed on 30 Apr 2023.
Epione Pharmaceuticals can be reached through the website epionepharma.com. Its registered office is in Pune, Maharashtra, India.
The registered office of Epione Pharmaceuticals is at Office No.804 8th Floor Suyog Center Jawaharlal Nehru Road Market Yard – Gulte, Kdi, Pune, Maharashtra, India – 411037.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages